Klinikum Wels-Grieskirchen
8
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
SARS-CoV-2 mRNA Vaccination in Patients With Hepatocellular Carcinoma Treated With Immune Checkpoint Inhibitors
Role: collaborator
Cardiac Magnetic Resonance Imaging Versus Computed Tomography to Guide Transcatheter Aortic Valve Replacement
Role: collaborator
Human Bone Graft for Hallux Valgus Correction According to the Austin Procedure
Role: lead
Austrian Registry on the Outcome of Monochorionic Pregnancies
Role: collaborator
Central Blood Pressure Over 24 Hours (ABPM) and Left Ventricular Mass
Role: lead
Anderson-Fabry Disease in Chronic Kidney Disease Patients Not on Renal Replacement Therapy
Role: lead
Pulsatile and Steady State Hemodynamics in Diastolic Heart Failure
Role: lead
Arterial Stiffness, Wave Reflections and Renal Failure
Role: lead
All 8 trials loaded